448
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma

, &
Pages 127-133 | Received 10 Jun 2021, Accepted 25 Oct 2021, Published online: 11 Jan 2022

References

  • Ciolino JB, Stefanescu CF, Ross AE, Salvador-Culla B, Cortez P, Ford EM, Wymbs KA, Sprague SL, Mascoop DR, Rudina SS, et al. 2014. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials. 35(1):432–439.
  • Desai A, Shukla M, Maulvi F, Ranch K. 2019. Ophthalmic and otic drug administration: novel approaches and challenges. Novel drug delivery technologies. Berlin: Springer; p. 335–381.
  • Friedman DS, Okeke CO, Jampel HD, Ying G-s, Plyler RJ, Jiang Y, Quigley HA. 2009. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmol J. 116(6):1097–1105.
  • Gupta H, Aqil M. 2012. Contact lenses in ocular therapeutics. Drug Discov Today. 17(9–10):522–527.
  • Guzman-Aranguez A, Colligris B, Pintor J. 2013. Contact lenses: promising devices for ocular drug delivery. J Ocul Pharmacol Ther. 29(2):189–199.
  • Halder A, Khopade AJ. 2021. Pharmacokinetics and pharmacology of latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles. Current Eye Research. 46(7):1031–1037.
  • Hiratani H, Fujiwara A, Tamiya Y, Mizutani Y, Alvarez-Lorenzo C. 2005. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials. 26(11):1293–1298.
  • Holgado M, Anguiano-Domínguez A, Martín-Banderas L. 2020. Contact lenses as drug-delivery systems: a promising therapeutic tool. Arch Soc Esp Oftalmol. 95(1):24–33.
  • Ibrahim AE, Saleh H, Elhenawee M. 2019. Assessment and validation of green stability indicating RP-HPLC method for simultaneous determination of timolol and latanoprost in pharmaceutical dosage forms using eco-friendly chiral mobile phase. Microchem J. 148:21–26.
  • Jones L, Powell CH. 2013. Uptake and release phenomena in contact lens care by silicone hydrogel lenses. Eye Contact Lens. 39(1):29–36.
  • Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mäder K. 2004. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 95(2):217–227.
  • Lanier OL, Christopher KG, Macoon RM, Yu Y, Sekar P, Chauhan A. 2020. Commercialization challenges for drug eluting contact lenses. Expert Opin Drug Deliv. 17(8):1133–1149.
  • Lanier OL, Manfre MG, Bailey C, Liu Z, Sparks Z, Kulkarni S, Chauhan A. 2021. Review of approaches for increasing ophthalmic bioavailability for eye drop formulations. AAPS PharmSciTech. 22(3):1–16.
  • Lee SE, Kim SR, Park M. 2015. Oxygen permeability of soft contact lenses in different pH, osmolality and buffering solution. Int J Ophthalmol. 8(5):1037–1042.
  • Martín-Hernández C, Bénet S, Marvin-Guy LF. 2005. Characterization and quantification of proteins in lecithins. J Agric Food Chem. 53(22):8607–8613.
  • Maulvi FA, Desai DT, Shetty KH, Shah DO, Willcox MD. 2021. Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery. Int J Pharm. 608:121090.
  • Maulvi FA, Parmar RJ, Desai AR, Desai DM, Shukla MR, Ranch KM, Shah SA, Shah DO. 2020. Tailored gatifloxacin Pluronic® F-68-loaded contact lens: addressing the issue of transmittance and swelling. Int J Pharm. 581:119279.
  • Maulvi FA, Patel PJ, Soni PD, Desai AR, Desai DT, Shukla MR, Ranch KM, Shah SA, Shah DO. 2020. Novel Poly(vinylpyrrolidone)-coated silicone contact lenses to improve tear volume during lens wear: in vitro and in vivo studies . ACS Omega. 5(29):18148–18154.
  • Maulvi FA, Ranch KM, Desai AR, Desai DT, Shukla MR. 2021. Ophthalmic preparations. Remington. Remington: Elsevier; p. 565–575.
  • Maulvi FA, Soni TG, Shah DO. 2016. A review on therapeutic contact lenses for ocular drug delivery. Drug Deliv. 23(8):3017–3026.
  • Oliveira PM, Sampaio TR, França LC, Gratieri T, Cunha-Filho M, Gelfuso GM. 2020. LC-MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin. J Pharm Biomed Anal. 187:113373.
  • Pandey SS, Patel MA, Desai DT, Patel HP, Gupta AR, Joshi SV, Shah DO, Maulvi FA. 2020. Bioavailability enhancement of repaglinide from transdermally applied nanostructured lipid carrier gel: optimization, in vitro and in vivo studies. J Drug Deliv Sci Technol. 57(101731):101731.
  • Peng C-C, Kim J, Chauhan A. 2010. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials. 31(14):4032–4047.
  • Phan C-M, Bajgrowicz-Cieslak M, Subbaraman LN, Jones L. 2016. Release of moxifloxacin from contact lenses using an in vitro eye model: impact of artificial tear fluid composition and mechanical rubbing. Trans Vis Sci Tech. 5(6):3–3.
  • Puértolas J, Martínez‐Morlanes M, Mariscal M, Medel F. 2011. Thermal and dynamic mechanical properties of vitamin E infused and blended ultra‐high molecular weight polyethylenes. J Appl Polym Sci. 120(4):2282–2291.
  • Ribeiro A, Veiga F, Santos D, Torres-Labandeira JJ, Concheiro A, Alvarez-Lorenzo C. 2012. Hydrophilic acrylic hydrogels with built-in or pendant cyclodextrins for delivery of anti-glaucoma drugs. Carbohydr Polym. 88(3):977–985.
  • Rouland J-F, Traverso CE, Stalmans I, El Fekih L, Delval L, Renault D, Baudouin C. 2013. Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma. Br J Ophthalmol. 97(2):196–200.
  • Schwartz GF, Quigley HA. 2008. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 53(6):S57–S68.
  • Shah R, Eldridge D, Palombo E, Harding I. 2014. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci. 25(1):59–75.
  • Torres-Luna C, Hu N, Tammareddy T, Domszy R, Yang J, Wang NS, Yang A. 2019. Extended delivery of non-steroidal anti-inflammatory drugs through contact lenses loaded with Vitamin E and cationic surfactants. Cont Lens Anterior Eye. 42(5):546–552.
  • Tripathi RC, Tripathi BJ, Ruben M. 1980. The pathology of soft contact lens spoilage. Ophthalmol J. 87(5):365–380.
  • Trotta M, Debernardi F, Caputo O. 2003. Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique. Int J Pharm. 257(1–2):153–160.
  • Watson P, Stjernschantz J, Group LS. 1996. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmol J. 103(1):126–137.
  • Xu B, Liu T. 2020. Travoprost loaded microemulsion soaked contact lenses: improved drug uptake, release kinetics and physical properties. J Drug Deliv Sci Technol. 57:101792.
  • Xu J, Li X, Sun F. 2010. Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release. Acta Biomater. 6(2):486–493.
  • Yuan H, Chen C-Y, Chai G-h, Du Y-Z, Hu F-Q. 2013. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm. 10(5):1865–1873.
  • Zhang X, Cao X, Qi P. 2020. Therapeutic contact lenses for ophthalmic drug delivery: major challenges. J Biomater Sci Polym Ed. 31(4):549–560.
  • Zhu Y, Sheng Y. 2020. Sustained delivery of epalrestat to the retina using PEGylated solid lipid nanoparticles laden contact lens. Int J Pharm. 587:119688.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.